Program
carboxymethylcellulose
Also written as “Carboxymethylcellulose and Glycerin based artificial tear”, “Optive” and “Carboxymethylcellulose sodium 0.5%, Glycerin 1.0%, Polysorbate 80 0.5%”.
Its studies are mostly in Dry Eye Syndromes · Keratoconjunctivitis Sicca, led by 3 companies.
Drug pageCarboxymethylcellulose: every studyAll 16 studies of it, academic ones too, with its approvals, label and forms.Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| AbbVieits history only | 70 open or running | phase 4since Jul 10, 2009 | Oct 21, 2005 | none ahead |
| Innovative Medical | 20 open or running | phase 4since Nov 9, 2006 | Nov 9, 2006 | none ahead |
| Andover Research Eye Instituteits history only | 11 open or running | phase 4since Jun 24, 2026 | Jun 24, 2026 | none ahead |
How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.
History and studies of Innovative Medical only; the figures above count every company.
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
- Nov 9, 2006First study: phase 4 study in Dry Eye SyndromesFirst studyNCT00399230 · United States
- May 2, 2007Phase 4 study in Dry Eye SyndromesNCT00469157 · 92 enrolled · United States
TargetBeta
Not stated by its company or a source we have read. Most early programs say nothing of it.
Studies
All 2 Innovative Medical leads, newest first. Each opens its study page.
| Study | Phase | Status | Primary completion | Size |
|---|---|---|---|---|
| NCT00469157Dry Eye Syndromes · United States | 4 | Completed | Apr 2008 | 92 |
| NCT00399230Dry Eye Syndromes · United States | 4 | Completed |
How it is read
Names in the registry
- “Carboxymethylcellulose and Glycerin based artificial tear”, 2 entries
- “Optive”, 2 entries
- “Carboxymethylcellulose sodium 0.5%, Glycerin 1.0%, Polysorbate 80 0.5%”, 1 entry
- “carboxymethylcellulose 0.5%/glycerin 0.9%”, 1 entry
- “Sodium Carboxymethylcellulose”, 1 entry
Conditions, from the studies’ own filings
- Dry Eye Syndromes, 8 studies
- Keratoconjunctivitis Sicca, 2 studies
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.